131 related articles for article (PubMed ID: 22270215)
1. Novel therapies for the treatment of metastatic melanoma.
Chouake J; Friedman A
J Drugs Dermatol; 2012 Feb; 11(2):271-3. PubMed ID: 22270215
[No Abstract] [Full Text] [Related]
2. [Treatment of metastatic melanoma: are we entering the era of targeted treatment?].
von Moos R; Cathomas R; Mark M; Hitz F
Praxis (Bern 1994); 2012 Oct; 101(22):1423-9. PubMed ID: 23117962
[TBL] [Abstract][Full Text] [Related]
3. [New hope in metastatic melanoma treatment?].
Guillot B
Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
[No Abstract] [Full Text] [Related]
4. Strides in melanoma announced: maximizing value comes next.
Tuma RS
J Natl Cancer Inst; 2011 Jul; 103(13):997-9. PubMed ID: 21693727
[No Abstract] [Full Text] [Related]
5. Targeted therapies for metastatic melanoma.
Chandra S; Pavlick AC
Dermatol Clin; 2012 Jul; 30(3):517-24. PubMed ID: 22800555
[TBL] [Abstract][Full Text] [Related]
6. [Immune checkpoint antibodies increase survival in patients with metastatic melanoma].
Fløe LE; Svane IM; Bastholt L; Schmidt H
Ugeskr Laeger; 2016 Aug; 178(33):. PubMed ID: 27550784
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
[TBL] [Abstract][Full Text] [Related]
8. Are we entering a new era in melanoma treatment? Lesson from ASCO 2011.
Mouawad R; Spano JP; Khayat D
Melanoma Res; 2011 Oct; 21(5):377-9. PubMed ID: 21900791
[No Abstract] [Full Text] [Related]
9. Current advances and perspectives in the treatment of advanced melanoma.
Livingstone E; Zimmer L; Vaubel J; Schadendorf D
J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863
[TBL] [Abstract][Full Text] [Related]
10. FDA approves new melanoma treatments.
Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):3. PubMed ID: 22396993
[No Abstract] [Full Text] [Related]
11. [Zelboraf. Longer term survival for advanced stage melanoma].
Sabourin G
Perspect Infirm; 2012; 9(5):64-5. PubMed ID: 22978138
[No Abstract] [Full Text] [Related]
12. [New treatment options for metastatic melanoma].
Tietze JK; Berking C
Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1462-7. PubMed ID: 24983194
[No Abstract] [Full Text] [Related]
13. Upcoming strategies for the treatment of metastatic melanoma.
Spagnolo F; Queirolo P
Arch Dermatol Res; 2012 Apr; 304(3):177-84. PubMed ID: 22350184
[TBL] [Abstract][Full Text] [Related]
14. The conquest of melanoma by immunotherapy.
Lejeune FJ
Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
[No Abstract] [Full Text] [Related]
15. An incidental finding.
Menon SK
J Fam Pract; 2013 Nov; 62(11):655-9. PubMed ID: 24288711
[TBL] [Abstract][Full Text] [Related]
16. Industry makes strides in melanoma.
Garber K
Nat Biotechnol; 2010 Aug; 28(8):763-4. PubMed ID: 20697383
[No Abstract] [Full Text] [Related]
17. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C
Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735
[No Abstract] [Full Text] [Related]
18. Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse.
Tauber M; Pages C; La Selva R; Schneider P; Chardin J; Osio A; Mourah S; Culine S; Vercellino L; Bagot M; Lebbé C
Eur J Dermatol; 2013; 23(5):702-3. PubMed ID: 24135270
[No Abstract] [Full Text] [Related]
19. [Issues around melanoma].
Haanen J
Ned Tijdschr Geneeskd; 2011; 155(45):A3836. PubMed ID: 22085568
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma.
Alonso-Castro L; Ríos-Buceta L; Vano-Galvan S; Moreno C; Soria-Rivas A; Jaén P
J Am Acad Dermatol; 2013 Jul; 69(1):e28-9. PubMed ID: 23768302
[No Abstract] [Full Text] [Related]
[Next] [New Search]